Relx (NYSE:RELX)‘s stock had its “hold” rating restated by research analysts at Berenberg Bank in a note issued to investors on Monday, The Fly reports.
Other equities analysts also recently issued research reports about the company. ABN Amro downgraded Relx from a “buy” rating to a “hold” rating in a research report on Wednesday, June 24th. Credit Suisse Group reaffirmed an “outperform” rating on shares of Relx in a research report on Thursday, March 12th. ValuEngine raised Relx from a “sell” rating to a “hold” rating in a research report on Friday, March 13th. CSFB reaffirmed an “outperform” rating on shares of Relx in a research report on Thursday, March 12th. Finally, UBS Group raised Relx from a “sell” rating to a “neutral” rating in a research report on Thursday, March 5th. They noted that the move was a valuation call. Six investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $26.00.
NYSE RELX opened at $23.62 on Monday. The company has a market cap of $45.54 billion, a P/E ratio of 19.85, a P/E/G ratio of 2.89 and a beta of 0.61. The company has a debt-to-equity ratio of 1.99, a quick ratio of 0.37 and a current ratio of 0.41. The business’s 50 day moving average price is $23.30 and its 200-day moving average price is $23.75. Relx has a fifty-two week low of $16.81 and a fifty-two week high of $27.25.
RELX PLC provides information based-analytics and decision tools for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals that enables progress in science, advance healthcare, and performance improvement.
Further Reading: Circuit Breakers
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.